Clinical Report: Involvement of Chymase-Positive Mast Cells in Cardiac Injury Linked to COVID-19
Overview
This study investigates the role of chymase-positive mast cells in myocardial injury among patients who died from severe COVID-19. Findings indicate a significant correlation between these mast cells and indicators of severe disease progression, including elevated troponin I levels.
Background
Acute myocardial injury is a common and serious complication of COVID-19, associated with increased mortality. Understanding the mechanisms behind cardiac damage is crucial for improving patient outcomes. This study focuses on the role of chymase-positive mast cells, which have been implicated in inflammatory responses and tissue remodeling.
Data Highlights
Parameter
Findings
MC Density
Low overall density with predominance of degranulated chymase-positive cells
Troponin I Levels
Strong association with chymase-positive MCs
Inflammatory Markers
Correlated with neutrophilic leukocytosis and monocytosis
Fibrosis
Increased MC presence associated with extensive interstitial and perivascular fibrosis
Key Findings
Chymase-positive mast cells were predominantly degranulated in cardiac tissue samples.
Significant correlation between chymase-positive MC density and elevated troponin I levels.
MC presence was linked to severe COVID-19 progression indicators, including neutrophilic leukocytosis.
Increased mast cell presence coincided with extensive fibrosis characterized by type III collagen.
Study supports the hypothesis that mast cells contribute to myocardial inflammation and fibrosis in COVID-19.
Clinical Implications
The findings suggest that targeting chymase-positive mast cells may provide a therapeutic avenue to mitigate cardiac complications in COVID-19 patients. Clinicians should consider monitoring troponin I levels and inflammatory markers as part of the assessment of myocardial injury in COVID-19.
Conclusion
Chymase-positive mast cells play a significant role in myocardial injury associated with COVID-19, highlighting their potential as a target for future therapeutic strategies. Further research is warranted to explore interventions that could reduce cardiac complications in affected patients.
by Andrey V. Budnevsky, Sergey N. Avdeev, Ekaterina D. Arkhipova, Djuro Kosanovic, Viktoria V. Shishkina, Tatiana A. Chernik, Evgeniy S. Ovsyannikov, Inna M. Perveeva, Andrey A. Filin, Roman E. Tokmachev, Alexander V. Pertsev, Elena E. Ivanova, Tatiana V. Samoylenko, Lyubov N. Antakova
